Aviva PLC Sells 60,056 Shares of Colgate-Palmolive Company $CL

Aviva PLC decreased its holdings in Colgate-Palmolive Company (NYSE:CL) by 2.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,199,064 shares of the company’s stock after selling 60,056 shares during the period. Aviva PLC owned about 0.27% of Colgate-Palmolive worth $173,770,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Colgate-Palmolive by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after acquiring an additional 1,026,985 shares in the last quarter. Geode Capital Management LLC increased its stake in Colgate-Palmolive by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock worth $1,754,657,000 after acquiring an additional 304,426 shares during the period. Norges Bank bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at $861,670,000. Deutsche Bank AG increased its stake in shares of Colgate-Palmolive by 33.9% in the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock valued at $857,040,000 after purchasing an additional 2,746,920 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of Colgate-Palmolive by 13.1% in the 3rd quarter. Invesco Ltd. now owns 8,467,993 shares of the company’s stock valued at $676,931,000 after purchasing an additional 978,943 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Sanford C. Bernstein started coverage on Colgate-Palmolive in a research report on Thursday. They set a “market perform” rating and a $96.00 price objective on the stock. The Goldman Sachs Group reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Bank of America dropped their price objective on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the company a “buy” rating in a research report on Tuesday, April 21st. Finally, JPMorgan Chase & Co. boosted their target price on Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $89.48 on Friday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The business’s 50 day simple moving average is $86.77 and its 200 day simple moving average is $86.23. The company has a market cap of $71.60 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 4.74 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter in the prior year, the business earned $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 8.4% on a year-over-year basis. Sell-side analysts forecast that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.